Rallybio Corp (RLYB) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 2020 - 2022
Historical data
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Rallybio Corp quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2020 to 2022.
- Rallybio Corp Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending December 31, 2022 was -$16 M, a 31.1% decline year-over-year.
- Rallybio Corp Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending December 31, 2022 was -$65.6 M, a 44.1% decline year-over-year.
- Rallybio Corp annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$65.6 M, a 44.1% decline from 2021.
- Rallybio Corp annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$45.5 M, a 82.5% decline from 2020.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)